-transparent.png){kind=logo}
With the aim of improving its biological and pharmaceutical profiles, two water soluble phosphate prodrugs of 3-AP, 3a and 3b were prepared. The detailed synthesis and the preliminary evaluation of these prodrugs are described.
Related Publications
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
January 1999,
Advances in enzyme regulation,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
February 2012,
Future oncology (London, England),
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
September 2002,
Cancer chemotherapy and pharmacology,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
August 2008,
Investigational new drugs,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
July 2013,
Gynecologic oncology,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
February 2006,
Journal of the Society for Gynecologic Investigation,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
January 2011,
Experimental and therapeutic medicine,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
January 2006,
CNS drug reviews,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
February 2011,
Cancer chemotherapy and pharmacology,
J Li, and
X Luo, and
Q Wang, and
L M Zheng, and
I King, and
T W Doyle, and
S H Chen
February 2001,
Current medicinal chemistry,
